Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study

Chia Ying Liu, Megha Parikh, David A. Bluemke, Pallavi Balte, James Carr, Stephen Dashnaw, Hooman D. Poor, Antoinette S. Gomes, Eric A. Hoffman, Steven M. Kawut, Joao A.C. Lima, David A. McAllister, Martin A. Prince, Jens Vogel-Claussen, R. Graham Barr*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Purpose: Chronic obstructive pulmonary disease (COPD) and particularly emphysema are characterized by stiffness of the aorta, due in part to accelerated elastin degradation in the lungs and aorta. Stiffness of the pulmonary arteries (PAs) may also be increased in COPD and emphysema, but data are lacking. We assessed PA stiffness using MRI in patients with COPD and related these measurements to COPD severity and percent emphysema. Materials and Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study recruited 290 participants, age 50–79 years with 10 or more packyears and free of clinical cardiovascular disease. COPD severity were defined on postbronchodilator spirometry by ATS/ERS criteria. Percent emphysema was defined as the percentage of regions of the lung < -950 Hounsfield units on full-lung computed tomography (CT). PA stain was defined by the percent change in cross-sectional PA area between systole and diastole on MRI. Blood flow across the tricuspid and mitral valves was assessed by phase-contrast MRI for determination of the ventricular diastolic dysfunction (E/A ratio). Results: PA strain was reduced in COPD compared with controls (P = 0.002) and was inversely correlated with COPD severity (P = 0.004). PA strain was inversely associated to percent emphysema (P = 0.01). PA strain was also markedly correlated with right ventricular diastolic dysfunction measured by E/A ratios in the fully adjusted mix models (P = 0.02). Conclusion: PA strain is reduced in COPD, related in part to percent emphysema on CT scan, which may have implications for pulmonary small vessel flow and right ventricular function. Level of Evidence: 2. Technical Efficacy: Stage 1. J. Magn. Reson. Imaging 2018;47:262–271.

Original languageEnglish (US)
Pages (from-to)262-271
Number of pages10
JournalJournal of Magnetic Resonance Imaging
Volume47
Issue number1
DOIs
StatePublished - Jan 2018

Funding

Contract grant sponsor: the National Institutes of Health; contract grant number: R01-HL093081; Contract grant number: R01-HL077612; Contract grant number: R01-HL075476; N01-HC95159-HC95169; Contract grant number: UL1-RR024156 The authors thank all investigators, staff, and participants of the MESA COPD Study for their valuable contributions. A full list of participating MESA Investigators and institutions can be found at http://www.mesa-nhlbi.org. This manuscript has been reviewed by the MESA Investigators for scientific content and consistency of data interpretation with previous MESA publications and significant comments have been incorporated before submission for publication. The MESA COPD Study is supported by the National Institutes of Health R01-HL093081, R01-HL077612, and R01-HL075476. MESA is supported by N01-HC95159-HC95169 and UL1-RR024156.

Keywords

  • MR flowing imaging
  • lung function/COPD
  • pulmonary artery
  • strain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study'. Together they form a unique fingerprint.

Cite this